Association Between the Sit-To-Stand Test and the Prognosis of Patients With Heart Failure

Recruiting Observational Study
Heart Failure Heart Failure NYHA Class IV Heart Failure; With Decompensation Heart Failure NYHA Class III Heart Failure NYHA Class II
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
68 (estimated)
Sponsor
Centro Universitário Augusto Motta · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Introduction: Heart failure (HF), among cardiovascular diseases, is the disease that has been increasing its incidence and prevalence the most in recent years in the world population, due to the aging of the population. In addition, HF is the most frequent hospital diagnosis in the elderly, and is the main cause of hospitalization, with significant expenditure in public and private health care wor…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with CDI; * Over 18 years of age; * With an Intensive Care Unit Mobility Scale (IMS) \> 4 at discharge from the ICU; * Able to sit and stand up from a chair without support from the upper limbs (ULs) will be included in the study. Exclusion Criteria: * Pat…
Contacts

Daiane Nascimento Camêlo, Master's student

+55 (21) 99452-1787

daianecamelo@souunisuam.com.br

CONTACT